137 results

Shire’s  offices at Citywest Business Campus, Dublin: the Footsie 100 Shire group is looking to build its pipeline of standalone speciality drugs. Photograph: Aidan Crawley/Bloomberg

Shire, the Irish-headquartered drugmaker, has made its biggest ever acquisition with a $5.2 billion deal for US biotechnology company NPS Pharmaceutic(...)

Labour MP  Margaret Hodge, chairman of the public accounts committee, has told PwC to “just clean up your act”. Photograph: PA

PricewaterhouseCoopers’ role in helping Shire Pharmaceuticals to cut its tax bill by lending billions from a Dublin subsidiary to one in Luxembourg th(...)

Scrutinised: PricewaterhouseCoopers. Photograph: Nicolas Bouvy/EPA

The flood of stories began at 9pm on Wednesday, when leaked PricewaterhouseCoopers documents revealed some of the arrangements that household-name com(...)

For the scheme to work, the Irish branch of the Luxembourg company had to be considered permanently established in this jurisdiction. Photograph: Thinkstock

The multinational pharmaceuticals group Shire opened a one-person Irish branch office in 2008 to which it allocated $3.78 billion in capital from Luxe(...)

Luxembourg’s prime minister, Xavier Bettel, held a press conference to defend the country’s tax practices. Photograph: Nicolas Bouvy/EPA

New disclosures about Luxembourg tax agreements involving billions of euro by companies with operations in Ireland are published today as politicia(...)

 Allergan shareholder Paulson & Co is said to be urging the Botox maker to merge with specialty pharmaceutical company Shire. Photo: Eric Luke/The Irish Times

Allergan shareholder Paulson & Co is said to be urging the Botox maker to merge with specialty pharmaceutical company Shire as an alternative to (...)

An office worker watching the FTSE 100, which slumped by another 2 per cent today as fears over the global economy triggered another bleak session for volatile stock markets. Photograph:  PA Wire

US stocks recovered from early losses as St. Louis Federal Reserve Bank President James Bullard said policy makers should consider delaying the end of(...)

The very Shire executives who baulked at the original acquisition proposal are demanding Abbvie follow through on its takeover while Abbvie is widely expected to withdraw a recommendation to its own shareholders to back the deal when its board meets on Monday.  Photograph: Aidan Crawley/Bloomberg

Cantillon: US biopharmaceuticals group Abbvie is in danger of proving the Obama administration and its truculent Congress right. Its increasing reluct(...)

Dublin-headquartered Shire stands to be paid a break-up fee of about $1.64 billion if Abbvie’s shareholders vote against the deal

US pharmaceutical company AbbVie has recommended that shareholders vote against its $55 billion takeover of Dublin-headquartered Shire in the wake of(...)

AbbVie had recently said it was still committed to the deal, which would have reduced the reliance on its Humira drug, the world’s top selling arthritis medicine which loses US patent protection in 2016

Chicago-based AbbVie said it was reconsidering its $55 billion takeover of Dublin-headquartered Shire weeks after the USgovernment moved to curb dea(...)

  • « First
  • Prev
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next
  • Last »